Atb Cap Markets upgraded shares of STERIS’ (TSE:STE – Free Report) to a strong-buy rating in a research note released on Sunday,Zacks.com reports.
STERIS’ Stock Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Read More
- Five stocks we like better than STERIS’
- How to Find Undervalued Stocks
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- How to Read Stock Charts for Beginners
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- 3 REITs to Buy and Hold for the Long Term
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
